微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2.76% | 2660% | 172.44% | 36/157 | 0.06% | 泽璟制药 | 44.02% | 行业排名> |
| 2025-12-31 | -3.81% | 70.71% | -30.48% | 108/157 | -4.46% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-09-30 | -2.92% | -15.42% | -97.3% | 120/157 | 1.31% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-06-30 | -1.48% | 26% | -1580% | 116/157 | 0.3% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-03-31 | 0.1% | 100% | 100.77% | 109/157 | -0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2024-12-31 | -13.01% | -69.84% | -414.23% | 122/157 | -9.62% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-09-30 | -2.53% | 18.12% | -26.5% | 123/157 | 4.28% | 百利天恒 | 181.27% | 行业排名> |
| 2024-06-30 | -2% | 12.28% | -4100% | 123/157 | 2.69% | 百利天恒 | 186.1% | 行业排名> |
| 2024-03-31 | 0.05% | 104.42% | 100.65% | 114/157 | 2.35% | 百利天恒 | 186.89% | 行业排名> |
| 2023-12-31 | -7.66% | -206.4% | -147.9% | 122/157 | -1% | 百利天恒 | 188.56% | 行业排名> |
| 2023-09-30 | -3.09% | -293.13% | -35.53% | 122/157 | 2.36% | 小方制药 | 41.8% | 行业排名> |
| 2023-06-30 | -2.28% | -268.89% | -101.77% | 120/157 | 1.48% | 拓新药业 | 20.51% | 行业排名> |
| 2023-03-31 | -1.13% | -216.49% | 54.8% | 124/157 | 1.37% | 拓新药业 | 19.87% | 行业排名> |
| 2022-12-31 | -2.5% | -170.03% | -256.25% | 114/157 | 0.79% | 拓新药业 | 19.91% | 行业排名> |
| 2022-09-30 | 1.6% | -69.58% | 18.52% | 99/157 | 2.86% | 小方制药 | 55.57% | 行业排名> |
| 2022-06-30 | 1.35% | -69.32% | 39.18% | 98/157 | 2.21% | 福元医药 | 25.41% | 行业排名> |
| 2022-03-31 | 0.97% | -60.25% | -72.83% | 91/157 | 1.59% | 小方制药 | 34.81% | 行业排名> |
| 2021-12-31 | 3.57% | -77.56% | -32.13% | 85/157 | 0.84% | 退市金泰 | 10.74% | 行业排名> |
| 2021-09-30 | 5.26% | -68.26% | 19.55% | 78/157 | 4.46% | ST人福 | 6.82% | 行业排名> |
| 2021-06-30 | 4.4% | -63.76% | 80.33% | 62/157 | 2.99% | 小方制药 | 71.99% | 行业排名> |
| 2021-03-31 | 2.44% | -54.39% | -84.66% | 55/157 | 2.49% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-12-31 | 15.91% | -31.04% | -3.98% | 30/157 | 3.8% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-09-30 | 16.57% | -6.07% | 36.49% | 11/157 | 3.13% | 哈三联 | 27.17% | 行业排名> |
| 2020-06-30 | 12.14% | 34.14% | 126.92% | 13/157 | 4.28% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-03-31 | 5.35% | 10.08% | -76.81% | 8/157 | 2.23% | 中哲精化 | 45.32% | 行业排名> |
| 2019-12-31 | 23.07% | 23.63% | 30.78% | 13/157 | 2.57% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-09-30 | 17.64% | 4.69% | 94.92% | 8/157 | 7.58% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-06-30 | 9.05% | -29.13% | 86.21% | 16/157 | 5.02% | 奥赛康 | 35% | 行业排名> |
| 2019-03-31 | 4.86% | -23.7% | -73.95% | 13/157 | 2.45% | 奥赛康 | 28.15% | 行业排名> |
| 2018-12-31 | 18.66% | -6.09% | 10.74% | 18/157 | 7.16% | 宏源药业 | 21.91% | 行业排名> |
| 2018-09-30 | 16.85% | 0.42% | 31.95% | 5/157 | 7.21% | 奥赛康 | 9.7% | 行业排名> |
| 2018-06-30 | 12.77% | 9.43% | 100.47% | 5/157 | 4.63% | 奥赛康 | 40.69% | 行业排名> |
| 2018-03-31 | 6.37% | -1.39% | -67.94% | 6/157 | 2.57% | 信立泰 | 25.93% | 行业排名> |
| 2017-12-31 | 19.87% | -16.23% | 18.41% | 12/157 | 9.62% | 昂利康 | 15.91% | 行业排名> |
| 2017-09-30 | 16.78% | -13.46% | 43.79% | 9/157 | 8.31% | 奥赛康 | 12.08% | 行业排名> |
| 2017-06-30 | 11.67% | -1.93% | 80.65% | 9/157 | 5.56% | 一品红 | 31.62% | 行业排名> |
| 2017-03-31 | 6.46% | 7.67% | -72.77% | 4/157 | 2.1% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-12-31 | 23.72% | -18.24% | 22.33% | 12/157 | 6.05% | 中哲精化 | 54.24% | 行业排名> |
| 2016-09-30 | 19.39% | -9.48% | 62.94% | 6/157 | 5.64% | 华东医药 | 7.2% | 行业排名> |
| 2016-06-30 | 11.9% | -10.86% | 98.33% | 8/157 | 3.52% | ST南新 | 81.7% | 行业排名> |
| 2016-03-31 | 6% | -4.31% | -79.32% | 8/157 | 2.69% | 德展健康 | 29.5% | 行业排名> |